VRTX
Vertex Pharmaceuticals Incorporated · Healthcare
SVP, Controller Paul M Silva sold $381K of Vertex Pharmaceuticals Incorporated
Sold$380,957
$243.58Price
1,564Shares
−8%Stake
What VRTX did after the filing
- The stock from Wed, Feb 19 close, $247.78
- −9.0%
- S&P 500, same days
- −26.8%
Measured over 30 trading days, to the Apr 1 close.
Traded Tue, Feb 18. Filed Wed, Feb 19, 11:38 AM ET, during the session. Returns use the Feb 19 close and the Apr 1 close. Not investment advice.